{"id":"administration-of-metronidazole-plus-amoxicillin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Nausea"},{"rate":"5-15","effect":"Diarrhea"},{"rate":"5-10","effect":"Metallic taste (metronidazole)"},{"rate":"5-15","effect":"Abdominal discomfort"},{"rate":"1-3","effect":"Allergic reaction (amoxicillin)"},{"rate":"5-10","effect":"Headache"},{"rate":"3-10","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is a nitroimidazole that disrupts bacterial DNA and is effective against anaerobic organisms and protozoa, while amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. This combination is commonly used for polymicrobial infections where both aerobic and anaerobic coverage is needed, such as in H. pylori eradication or mixed bacterial infections.","oneSentence":"Metronidazole and amoxicillin together provide broad-spectrum antimicrobial coverage by inhibiting bacterial cell wall synthesis and DNA replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:26:47.029Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"H. pylori infection eradication (as part of triple or quadruple therapy)"},{"name":"Polymicrobial infections with aerobic and anaerobic bacteria"},{"name":"Dental and oral infections"},{"name":"Intra-abdominal infections"}]},"trialDetails":[{"nctId":"NCT07492134","phase":"PHASE2","title":"APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-04-01","conditions":"Acute Uncomplicated Diverticulitis","enrollment":100},{"nctId":"NCT07455448","phase":"","title":"Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-03","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":7228},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT05206500","phase":"PHASE4","title":"NextGen - Clinical Implication of Next Generation Sequencing","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-05-17","conditions":"Urinary Tract Infections","enrollment":100},{"nctId":"NCT07260006","phase":"NA","title":"Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease","status":"RECRUITING","sponsor":"Can Tho University of Medicine and Pharmacy","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection, Peptic Ulcer","enrollment":80},{"nctId":"NCT05332444","phase":"PHASE4","title":"Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-04-11","conditions":"Helicobacter Pylori Infection","enrollment":450},{"nctId":"NCT03431688","phase":"NA","title":"Tailored Therapy for Clarithromycin-Resistant H. Pylori","status":"COMPLETED","sponsor":"Kangdong Sacred Heart Hospital","startDate":"2018-10-01","conditions":"Helicobacter Pylori Infection","enrollment":782},{"nctId":"NCT06443502","phase":"PHASE3","title":"A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-11-19","conditions":"Pouchitis","enrollment":30},{"nctId":"NCT07146594","phase":"PHASE4","title":"Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia","status":"NOT_YET_RECRUITING","sponsor":"Athens Medical Center","startDate":"2025-08-20","conditions":"Helicobacter Pylori Gastritis, Helicobacter Eradication","enrollment":150},{"nctId":"NCT06131021","phase":"PHASE3","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-04-25","conditions":"Periodontitis, Periodontal Diseases, Periodontal Pocket","enrollment":150},{"nctId":"NCT03130452","phase":"PHASE4","title":"Helicobacter Pylori Eradication Study","status":"COMPLETED","sponsor":"Inje University","startDate":"2016-12-17","conditions":"Helicobacter Pylori Infection","enrollment":423},{"nctId":"NCT05934227","phase":"NA","title":"Amoxicillin Plus Metronidazole in Periodontal Maintenance","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2023-07-01","conditions":"Periodontitis, Periodontal Pocket","enrollment":50},{"nctId":"NCT04140903","phase":"PHASE4","title":"Partial Oral Antibiotic Treatment for Bacterial Brain Abscess","status":"RECRUITING","sponsor":"Henrik Nielsen","startDate":"2020-11-06","conditions":"Brain Abscess, Cerebral Abscess","enrollment":400},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT06687473","phase":"PHASE4","title":"Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-01-01","conditions":"Helicobacter Pylori, Drug Resistance, Multiple, Virulence Factor","enrollment":13},{"nctId":"NCT06687499","phase":"PHASE4","title":"14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-08-22","conditions":"Helicobacter Pylori, Drug Resistance, Multiple","enrollment":46},{"nctId":"NCT05475431","phase":"","title":"Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Comorbidities and Coexisting Conditions, Real-world Outcome","enrollment":1053},{"nctId":"NCT04755179","phase":"","title":"Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population","status":"COMPLETED","sponsor":"Ramon Gorter","startDate":"2019-08-12","conditions":"Appendicitis, Appendix Mass, Appendicitis Perforated","enrollment":1308},{"nctId":"NCT05444218","phase":"NA","title":"Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2021-05-01","conditions":"Peri-Implantitis","enrollment":89},{"nctId":"NCT04669717","phase":"PHASE4","title":"Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies","status":"RECRUITING","sponsor":"University of Geneva, Switzerland","startDate":"2021-09-01","conditions":"Periodontal Diseases, Antibiotics, Pharmacokinetics","enrollment":45},{"nctId":"NCT04149327","phase":"PHASE4","title":"Systemic Amoxicillin Plus Metronidazole in Peri-implantitis Treatment","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2012-08-01","conditions":"Peri-implantitis, Periodontal Diseases","enrollment":62},{"nctId":"NCT01330719","phase":"NA","title":"Mechanisms and Treatment Response of Aggressive Periodontitis in Children","status":"COMPLETED","sponsor":"University of Florida","startDate":"2006-12","conditions":"Aggressive Periodontitis","enrollment":514},{"nctId":"NCT06275204","phase":"","title":"H. Pylori Screen-and-treat Study in a Population of Young Adults","status":"RECRUITING","sponsor":"University of Latvia","startDate":"2024-03-04","conditions":"Gastric Cancer, H Pylori Infection, H Pylori Eradication","enrollment":6800},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT06177119","phase":"NA","title":"Amoxicillin and Metronidazole During or After the Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2012-01-31","conditions":"Periodontitis","enrollment":72},{"nctId":"NCT03779074","phase":"PHASE3","title":"Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2018-09-03","conditions":"Helicobacter Pylori Infection","enrollment":918},{"nctId":"NCT03779087","phase":"NA","title":"Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Ping-I (William) Hsu, M.D.","startDate":"2018-07-11","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT04020458","phase":"NA","title":"Dental Intervention Plan for Chronic Kidney Disease Patients Awaiting or With Kidney Transplant","status":"TERMINATED","sponsor":"Augusta University","startDate":"2018-11-09","conditions":"Chronic Kidney Disease, Chronic Periodontitis, Generalized, Moderate","enrollment":11},{"nctId":"NCT05850117","phase":"NA","title":"Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2020-02-10","conditions":"Helicobacter Pylori Eradication","enrollment":240},{"nctId":"NCT05164887","phase":"","title":"Microbiota Implementation to Reduce Anastomotic Colorectal Leaks (MIRACLe)","status":"COMPLETED","sponsor":"S.Eugenio Hospital","startDate":"2020-12-01","conditions":"Colorectal Cancer, Surgery, LAP","enrollment":131},{"nctId":"NCT05669651","phase":"NA","title":"Explore the Efficacy and Safety of FMT With Different Bacterial Doses in the Treatment of Hepatic Encephalopathy","status":"UNKNOWN","sponsor":"Hainv Gao","startDate":"2022-12-01","conditions":"Hepatic Encephalopathy","enrollment":100},{"nctId":"NCT05726734","phase":"PHASE4","title":"Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-02-06","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT04660123","phase":"PHASE4","title":"A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":959},{"nctId":"NCT05635942","phase":"PHASE4","title":"Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2019-01-29","conditions":"Helicobacter Pylori","enrollment":88},{"nctId":"NCT04879992","phase":"NA","title":"Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2021-05-07","conditions":"Helicobacter Pylori Infection","enrollment":413},{"nctId":"NCT02185209","phase":"PHASE4","title":"Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics","status":"COMPLETED","sponsor":"Margareta Hultin","startDate":"2015-03","conditions":"Periodontal Diseases, Periimplantitis","enrollment":77},{"nctId":"NCT02345733","phase":"PHASE4","title":"Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis","status":"COMPLETED","sponsor":"Prof. Arie Levine","startDate":"2015-09-01","conditions":"Ulcerative Colitis (UC)","enrollment":20},{"nctId":"NCT04178187","phase":"NA","title":"The Role of Probiotics in the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Evangelismos Hospital","startDate":"2019-10-02","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT04748120","phase":"NA","title":"Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2020-12-28","conditions":"Covid19, Appendicitis, Cholecystitis, Acute","enrollment":2},{"nctId":"NCT02969928","phase":"PHASE2, PHASE3","title":"Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2015-03","conditions":"Aggressive Periodontitis","enrollment":46},{"nctId":"NCT04024527","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2019-07-25","conditions":"Helicobacter Pylori Infection","enrollment":306},{"nctId":"NCT04580355","phase":"PHASE4","title":"Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome","status":"UNKNOWN","sponsor":"University of Campinas, Brazil","startDate":"2021-07","conditions":"Microbial Colonization, Periodontal Diseases, Periodontal Inflammation","enrollment":30},{"nctId":"NCT03383120","phase":"NA","title":"Diode Laser for Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Geneva, Switzerland","startDate":"2017-10-10","conditions":"Peri-Implantitis, Implant Complication","enrollment":40},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT04769583","phase":"PHASE4","title":"14-day Quadruple Therapy Versus Triple Therapy in HP Eradication","status":"COMPLETED","sponsor":"mohamed bouchoucha","startDate":"2019-02-10","conditions":"Gastritis H Pylori","enrollment":121},{"nctId":"NCT03572777","phase":"NA","title":"Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.","status":"COMPLETED","sponsor":"Antonio Mestrovic","startDate":"2018-04-15","conditions":"Helicobacter Pylori Infection","enrollment":159},{"nctId":"NCT04107194","phase":"PHASE3","title":"Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.","status":"UNKNOWN","sponsor":"University of Bari","startDate":"2020-01-14","conditions":"Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain","enrollment":362},{"nctId":"NCT03358576","phase":"PHASE3","title":"Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2018-09-18","conditions":"Intra Abdominal Infections","enrollment":674},{"nctId":"NCT04621487","phase":"NA","title":"Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"University of Split, School of Medicine","startDate":"2019-01-15","conditions":"Helicobacter Pylori Infection","enrollment":80},{"nctId":"NCT03844776","phase":"NA","title":"Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery","status":"UNKNOWN","sponsor":"Taibah University","startDate":"2019-10-02","conditions":"Infection","enrollment":135},{"nctId":"NCT03374176","phase":"PHASE3","title":"Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes","status":"COMPLETED","sponsor":"Centro Universitario de Tonalá","startDate":"2014-03","conditions":"Periodontitis, Periodontal Pocket, Diabetes Mellitus","enrollment":42},{"nctId":"NCT01568944","phase":"NA","title":"Role of Infected Blood Dendritic Cells in Heart Disease Risk","status":"COMPLETED","sponsor":"Augusta University","startDate":"2012-03","conditions":"Chronic Periodontitis","enrollment":18},{"nctId":"NCT03658746","phase":"PHASE4","title":"Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Shandong University","startDate":"2019-01-01","conditions":"Helicobacter Pylori Infection","enrollment":420},{"nctId":"NCT03565484","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2019-01-01","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT04359966","phase":"NA","title":"Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia","status":"UNKNOWN","sponsor":"Slovenian Society for Gastroenterology and Hepatology","startDate":"2020-05-10","conditions":"Helicobacter Pylori Infection, Eradication Treatments","enrollment":560},{"nctId":"NCT04353362","phase":"PHASE4","title":"Alternative Antibiotic Regimen in Periodontitis Treatment","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2017-04-01","conditions":"Amoxicillin, Metronidazole, Ofloxacin","enrollment":74},{"nctId":"NCT02954393","phase":"NA","title":"Amoxicillin and Metronidazole During Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2015-05","conditions":"Chronic Periodontitis","enrollment":180},{"nctId":"NCT03733379","phase":"PHASE3","title":"Systemic Probiotics in the Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2018-11-05","conditions":"Periodontitis","enrollment":176},{"nctId":"NCT03080103","phase":"","title":"Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis","status":"COMPLETED","sponsor":"Mauro Podda","startDate":"2017-06-01","conditions":"Acute Appendicitis, Appendicitis Recurrent, Appendectomy","enrollment":300},{"nctId":"NCT01967329","phase":"PHASE4","title":"CANHelp Working Group Treatment Trials","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2008-11","conditions":"Helicobacter Pylori Infection","enrollment":338},{"nctId":"NCT03557437","phase":"PHASE4","title":"High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-05-25","conditions":"Helicobacter Pylori Infection","enrollment":216},{"nctId":"NCT02839421","phase":"PHASE4","title":"Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment","status":"UNKNOWN","sponsor":"Facultad Nacional de Salud Publica","startDate":"2015-12","conditions":"Aggressive Periodontitis","enrollment":36},{"nctId":"NCT03837990","phase":"","title":"One Sequencing Find All for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2019-05-01","conditions":"Helicobacter Pylori Infection, Resistant Infection","enrollment":60},{"nctId":"NCT03933501","phase":"PHASE4","title":"Amoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2006-01-01","conditions":"Generalized Aggressive Periodontitis","enrollment":48},{"nctId":"NCT03219723","phase":"","title":"Drug Use Surveillance of Takecab for \"Supplement to Helicobacter Pylori Eradication\"","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-09-01","conditions":"Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other","enrollment":560},{"nctId":"NCT03884348","phase":"","title":"Tailored H. Pylori Eradication Based on Clarithromycin Resistance","status":"COMPLETED","sponsor":"Kangdong Sacred Heart Hospital","startDate":"2017-01-01","conditions":"Helicobacter Pylori Infection, Antibiotic Resistant Strain","enrollment":431},{"nctId":"NCT03499184","phase":"NA","title":"Adjunctive Probiotics in Chronic Periodontitis","status":"COMPLETED","sponsor":"Ziauddin Hospital","startDate":"2017-11-01","conditions":"Chronic Periodontitis, Probiotics","enrollment":60},{"nctId":"NCT02223702","phase":"PHASE4","title":"Alternative Antibiotic Regime in the Treatment of GAgP","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2011-05","conditions":"Generalized Aggressive Periodontitis, Aggressive Periodontitis","enrollment":39},{"nctId":"NCT03727620","phase":"PHASE1, PHASE2","title":"Doxycycline in the Treatment of Aggressive Periodontitis","status":"COMPLETED","sponsor":"Mohammed V Souissi University","startDate":"2014-01-06","conditions":"Aggressive Periodontitis","enrollment":24},{"nctId":"NCT00002682","phase":"PHASE2","title":"Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1995-08-10","conditions":"Lymphoma","enrollment":5},{"nctId":"NCT03435900","phase":"PHASE2","title":"Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Herlev Hospital","startDate":"2018-02-14","conditions":"Appendicitis Perforated","enrollment":13},{"nctId":"NCT02795793","phase":"NA","title":"Non-operative Management for Appendicitis in Children","status":"UNKNOWN","sponsor":"Sydney Children's Hospitals Network","startDate":"2016-05","conditions":"Acute Focal Appendicitis, Appendicitis","enrollment":226},{"nctId":"NCT03177629","phase":"PHASE3","title":"H. Pylori Eradication for Moderate ITP","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2017-05-23","conditions":"Immune Thrombocytopenic Purpura, Helicobacter Pylori, Immune Thrombocytopenia","enrollment":54},{"nctId":"NCT02935010","phase":"PHASE4","title":"Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2017-02-05","conditions":"Helicobacter Pylori Infection","enrollment":382},{"nctId":"NCT03413020","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT03610217","phase":"NA","title":"Pragmatic Clinical Trials in Scleroderma","status":"UNKNOWN","sponsor":"University of West London","startDate":"2018-10","conditions":"Scleroderma, Systemic, Sclerosis, Systemic","enrollment":400},{"nctId":"NCT03583476","phase":"","title":"The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2018-04-01","conditions":"Helicobacter Pylori Infection","enrollment":1821},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT02732249","phase":"PHASE4","title":"Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2016-04-01","conditions":"Helicobacter Pylori Infection","enrollment":66},{"nctId":"NCT03299725","phase":"PHASE4","title":"Bismuth Based Quadruple Therapy 10 Days in Children","status":"UNKNOWN","sponsor":"Queen Fabiola Children's University Hospital","startDate":"2017-11-24","conditions":"Helicobacter Pylori Infection","enrollment":120},{"nctId":"NCT02576236","phase":"NA","title":"Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-05","conditions":"H Pylori Infection Eradication, Antibiotics Therapeutic Strategies, H Pylori Eradication","enrollment":2500},{"nctId":"NCT01848379","phase":"NA","title":"White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis","status":"UNKNOWN","sponsor":"Zentrum fuer Zahn-, Mund- und Kieferheilkunde","startDate":"2012-01","conditions":"Chronic Periodontitis, Diabetes Mellitus, Type 2","enrollment":45},{"nctId":"NCT01725906","phase":"PHASE4","title":"Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-11","conditions":"Self Efficacy","enrollment":450},{"nctId":"NCT03132714","phase":"PHASE2, PHASE3","title":"Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2015-03","conditions":"Aggressive Periodontitis, Generalized","enrollment":46},{"nctId":"NCT02988089","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2017-04-20","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":480},{"nctId":"NCT01264822","phase":"","title":"Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-01-13","conditions":"Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive","enrollment":108},{"nctId":"NCT03043066","phase":"NA","title":"Serum TRAP-5b Levels in Patients With Generalized Chronic Periodontitis","status":"COMPLETED","sponsor":"Meenakshi Ammal Dental College and Hospital","startDate":"2016-03-01","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT02217722","phase":"NA","title":"Use of the Ulcerative Colitis Diet for Induction of Remission","status":"TERMINATED","sponsor":"Prof. Arie Levine","startDate":"2014-10","conditions":"Ulcerative Colitis (UC)","enrollment":9},{"nctId":"NCT02741414","phase":"NA","title":"A Multi-center Study for Eradication of Refractory Helicobacter Pylori","status":"UNKNOWN","sponsor":"Taizhou Hospital","startDate":"2016-06","conditions":"Gastritis","enrollment":4428},{"nctId":"NCT01211223","phase":"PHASE4","title":"Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis.","status":"COMPLETED","sponsor":"University of Chile","startDate":"2010-01","conditions":"Chronic Periodontitis, Clinical and Microbiological Effects","enrollment":42},{"nctId":"NCT02689583","phase":"NA","title":"A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2016-03","conditions":"Gastritis, Gastric Ulcer","enrollment":3000},{"nctId":"NCT02045251","phase":"PHASE4","title":"An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection","status":"WITHDRAWN","sponsor":"American University of Beirut Medical Center","startDate":"2013-06","conditions":"Treatment of H. Pylori Infection","enrollment":""},{"nctId":"NCT01547559","phase":"NA","title":"Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2007-06","conditions":"Non-steroidal Anti-inflammatory Drug Adverse Reaction","enrollment":369},{"nctId":"NCT02197260","phase":"PHASE4","title":"Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing","status":"COMPLETED","sponsor":"University of Geneva, Switzerland","startDate":"2008-09","conditions":"Chronic Periodontitis","enrollment":80},{"nctId":"NCT02135952","phase":"PHASE4","title":"Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-09","conditions":"Periodontitis","enrollment":58},{"nctId":"NCT01168063","phase":"NA","title":"Molecular Detection of Antibiotic Resistance and H Pylori Eradication","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-02","conditions":"Helicobacter Pylori Infection","enrollment":1386},{"nctId":"NCT01837199","phase":"PHASE4","title":"MTZ Plus AMX in the Treatment of Smokers and Non-smokers","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis, Smoking","enrollment":64},{"nctId":"NCT01602874","phase":"PHASE3","title":"Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2011-01","conditions":"Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":51,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Administration of Metronidazole plus Amoxicillin","genericName":"Administration of Metronidazole plus Amoxicillin","companyName":"University of Chile","companyId":"university-of-chile","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole and amoxicillin together provide broad-spectrum antimicrobial coverage by inhibiting bacterial cell wall synthesis and DNA replication. Used for H. pylori infection eradication (as part of triple or quadruple therapy), Polymicrobial infections with aerobic and anaerobic bacteria, Dental and oral infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}